FolioLanternBeta
EWEdwards Lifesciences

Daniel Lippis

Cvp, Tavr at Edwards Lifesciences, as of Oct 8, 2026Sold $925K of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
40K
shares held after the latest filing, Edwards Lifesciences
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
11K
shares sold, past 12 months
13
days with sales
$87K
largest single day, Jan 9, 2026
1
company filed for

Share of stake sold at Edwards Lifesciences is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $84K under a disclosed planNovDec 2025: $86K under a disclosed planDecJan 2026: $87K under a disclosed planJanFebMar 2026: $87K under a disclosed planMarApr 2026: $83K under a disclosed planAprMay 2026: $220K under a disclosed plan$220KMayJun 2026: $57K under a disclosed planJunJul 2026: $57K under a disclosed planJulAug 2026: $57K under a disclosed planAugSep 2026: $54K under a disclosed planSepOct 2026: $53K under a disclosed planOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Edwards Lifesciences (EW)Cvp, TavrJan 8, 2024Oct 8, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.